RankAlpha logo
Back to Rankings

CI

Cigna GroupB
NYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart
Current thesis
Q2 revenue rose 7% year over year, adjusted EPS increased to $7.78 from $7.20, and Cigna Healthcare pretax adjusted income rose 17%. Specialty and Care Services profit rose 22%, supporting the case that those businesses can offset pharmacy-benefit pressure.
Posture
Constructive
Lead driver
Value
What changed
6 setup hits (3d) with net bullish as of 2026-10-25.
What can break
Medical-cost and pricing assumptions could challenge the 83.7%–84.7% 2026 Healthcare medical care ratio outlook. [#SEC-8K-2026-07-30]
Momentum
75
Value
69
Sentiment
42
Setup hits (3d)
6 · Net Bullish
AI TargetsBase $285.00 · Bull $320.00 · Bear $220.00Analysis 2026-09-25; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-25 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $342.09
Why
Momentum75 · Δ7d +31.0
Value69 · Δ7d +0.0
Sentiment42 · Δ7d -1.2
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • 6 setup hits (3d) with net bullish as of 2026-10-25.
  • • Value remains the lead driver in the composite, 7D delta +0.0.

Contradictions & invalidation

  • • Medical-cost and pricing assumptions could challenge the 83.7%–84.7% 2026 Healthcare medical care ratio outlook. [#SEC-8K-2026-07-30]
  • • Pharmacy-benefit contract-renewal economics may continue to pressure profit despite revenue growth. [#SEC-8K-2026-07-30]
  • • Evernorth pretax adjusted income declined 2% despite higher revenue; Pharmacy Benefit Services profit fell 27%.

Catalyst clock

2026-12-31

2026 adjusted-earnings outlook

Lead driver: Value · See fundamentals
Momentum
75
8% active weight
Current posture
7d trendImproving
Δ7d
+31.0
Δ21d
+38.9
Value
69
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.8
Sentiment
42
45% active weight
Current posture
7d trendSoftening
Δ7d
-1.2
Δ21d
-20.7
Why this grade

Composite grade B. Momentum 75.1 / Value 68.7 / Sentiment 41.9

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-25. Scenario method

B+
Bull case
0%
Probability
Target price
$320.00
Analysis reference price unavailable
Analysis 2026-09-25 · RankAlpha Sentiment Codex
Most likely
B
Base case
1%
Probability
Target price
$285.00
Analysis reference price unavailable
Analysis 2026-09-25 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$220.00
Analysis reference price unavailable
Analysis 2026-09-25 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$81.11B
Beta
0.28
Shares Out
264.24M
P/E (TTM)
12.5
P/S (TTM)
0.28
P/FCF (TTM)
12.99
Rev YoY
+6.5%
EPS YoY
+10.1%
Gross Margin
+9.6%
Op Margin
+3.9%
Net Debt
$23.79B
Current Ratio
0.85
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data